Skip to content
ClientRx

Heavy disclosure

Investigational products carry the most caveats on this site.

Peptide programs described as investigational are not FDA-approved for the uses discussed. Evidence is limited, availability is restricted, and a provider may decline them outright.

Read this before considering a peptide program

  • These products are not FDA-approved for the uses discussed on this site.
  • Evidence is preliminary, limited, or drawn from non-human research.
  • Long-term safety data is not established.
  • Purity, potency, and formulation vary widely across sources.
  • Availability is subject to independent legal, clinical, pharmacy, and regulatory review.
  • A licensed provider may decline these programs entirely, and often will.

Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.

Alternatives

Consider a program with an established evidence base first.

Most goals people bring to peptide programs are better served by a category with approved products and structured monitoring.

Compare programs before committing.

Clinical status appears on every program card, program page, and again in the cart.